{
    "2018-07-31": [
        [
            {
                "time": "",
                "original_text": "推荐评级医药行业周报：论医药回调后的投资机会",
                "features": {
                    "keywords": [
                        "医药",
                        "回调",
                        "投资机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：重点推荐低估值高成长龙头仁和药业",
                "features": {
                    "keywords": [
                        "医药",
                        "低估值",
                        "高成长",
                        "仁和药业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中金医药月度7+5组合：8月组合",
                "features": {
                    "keywords": [
                        "中金",
                        "医药",
                        "月度组合",
                        "8月"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "快讯：医疗电商板块持续走高 汤臣倍健快速封涨停",
                "features": {
                    "keywords": [
                        "医疗电商",
                        "汤臣倍健",
                        "涨停"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "7月31日券商晨会研报汇编",
                "features": {
                    "keywords": [
                        "券商晨会",
                        "研报汇编"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业日报：5家药企的缬沙坦致癌物超出限值",
                "features": {
                    "keywords": [
                        "医药",
                        "缬沙坦",
                        "致癌物",
                        "超标"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "隆华节能中报业绩大增150.44%，管理革新和业务转型助力二次腾飞",
                "features": {
                    "keywords": [
                        "隆华节能",
                        "中报",
                        "业绩增长",
                        "管理革新",
                        "业务转型"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "节能环保"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}